Pharmacoepidemiology and Drug Safety

Aims & Scope

The aim of Pharmacoepidemiology and Drug Safety is to provide an international forum for the communication and evaluation of data, methods and opinion in the discipline of pharmacoepidemiology.

The Journal publishes peer-reviewed reports of original research, invited reviews and a variety of guest editorials and commentaries embracing scientific, medical, statistical, legal and economic aspects of pharmacoepidemiology and post-marketing surveillance of drug safety.

Appropriate material in these categories may also be considered for publication as a Brief Report.

Particular areas of interest include: design, analysis, results, and interpretation of studies looking at the benefit or safety of specific pharmaceuticals, biologics, or medical devices, including studies in pharmacovigilance, postmarketing surveillance, pharmacoeconomics, patient safety, molecular pharmacoepidemiology, or any other study within the broad field of pharmacoepidemiology; comparative effectiveness research relating to pharmaceuticals, biologics, and medical devices.

Comparative effectiveness research is the generation and synthesis of evidence that compares the benefits and harms of alternative methods to prevent, diagnose, treat, and monitor a clinical condition, as these methods are truly used in the real world; methodologic contributions of relevance to pharmacoepidemiology, whether original contributions, reviews of existing methods, or tutorials for how to apply the methods of pharmacoepidemiology; assessments of harm versus benefit in drug therapy; patterns of drug utilization; relationships between pharmacoepidemiology and the formulation and interpretation of regulatory guidelines; evaluations of risk management plans and programmes relating to pharmaceuticals, biologics and medical devices.

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	2.4
2024	2.40

SJR (SCImago Journal Rank)

Year	Value
2024	1.022

Quartile

Year	Value
2024	Q1

h-index

Year	Value
2024	113

Journal Rank

Year	Value
2024	4651

Journal Citation Indicator

Year	Value
2024	1101

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science
• Medline
• Embase

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• The new Swedish Prescribed Drug Register—Opportunities for pharmacoepidemiological research and experience from the first six months

  Citation: 1493

  Authors: Björn, Niklas, C., Andrejs, Petra, Ulf, Ingemar, Anders, Barbro, Måns

• Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports

  Citation: 1322

  Authors: S. J. W., P. C., S.

• Validation of the national health insurance research database with ischemic stroke cases in Taiwan

  Citation: 1126

  Authors: Ching‐Lan, Yea‐Huei Yang, Swu‐Jane, Cheng‐Han, Ming Liang

• A comparison of measures of disproportionality for signal detection in spontaneous reporting systems for adverse drug reactions

  Citation: 1025

  Authors: Eugéne P., Andrew, Hubert G. M., Marie, Roland, Antoine C. G.

• Methods for evaluation of medication adherence and persistence using automated databases

  Citation: 852

  Authors: Susan E., Kristijan H., Feride, K. Arnold

• The reporting odds ratio and its advantages over the proportional reporting ratio

  Citation: 782

  Authors: Kenneth J., Stephan, Susan T.

• Quantitative signal detection using spontaneous ADR reporting

  Citation: 678

  Authors: A., S. J. W.

• Sensitivity analysis and external adjustment for unmeasured confounders in epidemiologic database studies of therapeutics

  Citation: 570

  Authors: Sebastian

• Validation studies of the health improvement network (THIN) database for pharmacoepidemiology research

  Citation: 512

  Authors: James D., Rita, Warren B., Xingmei, Brian L.

• Increasing deaths from opioid analgesics in the United States

  Citation: 500

  Authors: Leonard J., Daniel S., Yongli

---